Skip to main content
OpenTrials

Clinical trial condition

Fallopian Tube Cancer

Explore clinical trials studying Fallopian Tube Cancer. Study availability and eligibility vary by location and protocol.

330 public trials 46 recruiting studies
Refine in advanced search Browse all conditions

Fallopian Tube Cancer trial results

Completed

Study of Ramucirumab in Ovarian Cancer

NCT00721162

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • ImClone Investigational Site Hollywood, Florida, United States
  • ImClone Investigational Site Orlando, Florida, United States
  • ImClone Investigational Site Chicago, Illinois, United States
  • ImClone Investigational Site Marrero, Louisiana, United States
View all 13 locations
View Trial Details
Completed

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

NCT01666444

Conditions
Adnexal Diseases, Brenner Tumor, Carcinoma, +26 more
Locations
  • St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Winthrop P. Rockefeller Cancer Institute - University of Arkansas Little Rock, Arkansas, United States
  • Providence Saint Joseph Medical Center Burbank, California, United States
  • Kaiser Permanente Medical Center Hayward, California, United States
View all 136 locations
View Trial Details
Completed

A Study LY2228820 for Recurrent Ovarian Cancer

NCT01663857

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • St Josephs Hospital and Medical Center Phoenix, Arizona, United States
  • Arizona Oncology Associates, P.C. Tucson, Arizona, United States
  • Sarasota Memorial Hospital Sarasota, Florida, United States
  • H Lee Moffitt Cancer Center Tampa, Florida, United States
View all 30 locations
View Trial Details
Completed

Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin

NCT00993616

Conditions
Adnexal Diseases, Brenner Tumor, Carcinoma, +32 more
Locations
  • Saint Francis Hospital and Medical Center Hartford, Connecticut, United States
  • The Hospital of Central Connecticut New Britain, Connecticut, United States
  • Beebe Medical Center Lewes, Delaware, United States
  • Christiana Care Health System-Christiana Hospital Newark, Delaware, United States
View all 81 locations
View Trial Details
Completed

Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)

NCT00085358

Conditions
Adnexal Diseases, Brenner Tumor, Carcinoma, +35 more
Locations
  • University of California Medical Center At Irvine-Orange Campus Orange, California, United States
  • Colorado Gynecologic Oncology Group Aurora, Colorado, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
View all 16 locations
View Trial Details
Completed

Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

NCT00079430

Conditions
Adnexal Diseases, Brenner Tumor, Carcinoma, +34 more
Locations
  • University of California Medical Center At Irvine-Orange Campus Orange, California, United States
  • University of Chicago Chicago, Illinois, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View all 19 locations
View Trial Details

Related conditions